CKS1B and lung carcinoma: found that overexpression of CKS1B achieved in lung cancer cells through lentiviral infection enhanced drug resistance by inhibiting cisplatin (CDDP)- and doxorubicin (DOX)-induced apoptosis, supporting the critical role of CKS1B in lung cancer progression (73).